LPL Financial’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Buy |
37,335
+12,892
| +53% | +$435K | ﹤0.01% | 3509 |
|
|
2025
Q1 | $777K | Buy |
24,443
+6,963
| +40% | +$221K | ﹤0.01% | 3726 |
|
|
2024
Q4 | $679K | Buy |
17,480
+225
| +1% | +$8.74K | ﹤0.01% | 3780 |
|
|
2024
Q3 | $776K | Buy |
17,255
+4,399
| +34% | +$198K | ﹤0.01% | 3576 |
|
|
2024
Q2 | $537K | Buy |
12,856
+680
| +6% | +$28.4K | ﹤0.01% | 3757 |
|
|
2024
Q1 | $554K | Buy |
12,176
+662
| +6% | +$30.1K | ﹤0.01% | 3643 |
|
|
2023
Q4 | $532K | Buy |
11,514
+683
| +6% | +$31.6K | ﹤0.01% | 3574 |
|
|
2023
Q3 | $441K | Sell |
10,831
-88
| -0.8% | -$3.58K | ﹤0.01% | 3561 |
|
|
2023
Q2 | $529K | Sell |
10,919
-2,801
| -20% | -$136K | ﹤0.01% | 3368 |
|
|
2023
Q1 | $676K | Sell |
13,720
-1,707
| -11% | -$84.1K | ﹤0.01% | 3081 |
|
|
2022
Q4 | $781K | Sell |
15,427
-90
| -0.6% | -$4.55K | ﹤0.01% | 2836 |
|
|
2022
Q3 | $779K | Buy |
15,517
+2,987
| +24% | +$150K | ﹤0.01% | 2722 |
|
|
2022
Q2 | $612K | Sell |
12,530
-5,189
| -29% | -$253K | ﹤0.01% | 3017 |
|
|
2022
Q1 | $1.07M | Sell |
17,719
-5,729
| -24% | -$344K | ﹤0.01% | 2560 |
|
|
2021
Q4 | $1.86M | Sell |
23,448
-3
| -0% | -$238 | ﹤0.01% | 2135 |
|
|
2021
Q3 | $2.08M | Buy |
23,451
+15,017
| +178% | +$1.33M | ﹤0.01% | 2005 |
|
|
2021
Q2 | $840K | Buy |
8,434
+608
| +8% | +$60.6K | ﹤0.01% | 2710 |
|
|
2021
Q1 | $704K | Buy |
7,826
+3,437
| +78% | +$309K | ﹤0.01% | 2715 |
|
|
2020
Q4 | $415K | Buy |
+4,389
| New | +$415K | ﹤0.01% | 2910 |
|